Funding · Company

Antiva Biosciences, Inc.

Redwood City, CABiotech & Pharma

Antiva Biosciences, Inc. of Redwood City, CA has disclosed $39M across 1 Form D offering filed with the SEC on Oct 11, 2024.

$39M

Total disclosed

Form D offering

Offerings on file

Each amount is as reported on that filing, cumulative across its own amendments. Newest first.

$39M

Form D · Oct 11, 2024 ↗

Q4 2024 · 1 amendment, first filed May 5, 2023 · target $53M

Filing details

HeadquartersRedwood City, CAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001563355Offerings on file1

Links

All SEC filings for this company ↗ antivabio.com ↗ More biotech & pharma raises →

Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →